Physicochemical and bioassay directed GC-MS analyses of chloroform extract of pteris cretica L.

Document Type

Article

Publication Date

6-1-2022

Abstract

This study was aimed to explore the potential of Pteris cretica L. to be used as herbal remedy. The P. cretica dried plant powder was subjected to a standard physicochemical (proximate analysis) protocol, which showed promising results and was consistent with the WHO recommended ranges that are required to use the plant as a remedy. To identify the bioactive chemical constituents of chloroform extract, the extract was subjected to a series of column chromatography and p-HPLC through the antibacterial and antioxidant bioassays guidance. The two most bioactive sub-fractions of chloroform extract were subjected to GC-MS analysis which revealed the presence of seventeen compounds, the major constituents being eicosane (16.8%), hexadecane (14.1%), methyl hexadecanoate (11.2%), 3,3,8-trimethyldecane (9.1%), 2,6,10-trimethyldodecane (7.8%), tricosane (5.1%) and tetradecane (3.86%). Proximate analysis results show that P. cretica plant is good for herbal remedy, and the bioassay results on chloroform fractions and sub-fractions show that this plant has significant antibacterial and antioxidant potentials. To use this plant as herbal remedy, there is need in further exploration.

Keywords

Pteris cretica L, Bioassay guidelines, GC-MS analysis, Proximate analysis, Antibacterial, Antioxidant

Divisions

CHEMISTRY

Funders

None

Publication Title

Pharmaceutical Chemistry Journal

Volume

56

Issue

3

Publisher

Springer

Publisher Location

ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES

This document is currently not available here.

Share

COinS